Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.

Podobné jednotky

• The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
  Autor: Hubert, A, a další
  Vydáno: (1999)
• Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations
  Autor: Kadouri, Luna, a další
  Vydáno: (2007)
• Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
  Autor: Levy-Lahad, E, a další
  Vydáno: (1997)
• An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews.
  Autor: Theodor, L., a další
  Vydáno: (1998)
• The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
  Autor: Abeliovich, D, a další
  Vydáno: (1997)